Cellectar Biosciences, Inc. — Director's Dealing 2016

Jul 6, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cellectar Biosciences, Inc. (CLRB)
CIK: 0001279704
Period of Report: 2016-07-05

Reporting Person: NEIS JOHN (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-07-05	Stock option (right to buy)	$3.34	A	22500	Acquired	2026-07-05	Common Stock (22500)	Direct